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CDObjective: Using nationwide population-based data from Taiwan’s National Health
Insurance database, we examined the association between hospitals’ coronary artery
bypass grafting surgery volume and 5-year major adverse cardiovascular events.
Methods: We used Taiwan’s National Health Insurance claims data linked to the
Cause of Death file for the years approximately 1997 to 2004. All 5718 patients
who underwent nonemergency coronary artery bypass grafting operations during
1997 through 1999 were classified into one of 4 hospital volume groups: 282 cases
or less (low volume, n 5 1584 patients), 283 to 517 cases (medium volume, n 5
1317), 518 to 725 cases (high volume, n 5 1437), and 726 cases or more (very
high volume, n 5 1380).
Results: Increasing hospital volume is associated with increasing 5-year major
adverse cardiovascular event–free survival (72.0%, 75.5%, 76.9%, and 79.4% in
low-volume, medium-volume, high-volume, and very high-volume hospitals, respec-
tively). Cox regression analysis shows that increasing hospital volume predicts
a systematic decrease in adjusted major adverse cardiovascular event hazard at 5
years. The 5-year major adverse cardiovascular event hazard ratios for high-volume
and very high-volume hospitals were 0.884 (95% confidence interval, 0.809–0.965)
and 0.811 (95% confidence interval, 0.728–0.904) relative to low-volume hospitals
after adjusting for patient demographics and economic status, initial case severity,
coronary artery bypass grafting procedure attributes, and hospital characteristics.
Conclusions: The findings suggest that high-volume hospitals have some processes,
infrastructure/personnel factors, or both that seem to produce not only better short-
term outcomes but also better long-term outcomes.
T
here is a growing recognition of the relatively better postoperative outcomes
for high-risk procedures with increasing provider volumes. Policymakers in-
ternationally have responded with regionalization policies and incentives to
concentrate the volumes of high-risk procedures in a few hospitals. In Canada and
the United Kingdom, a policy of regionalization of high-risk procedures was imple-
mented.1 Coronary artery bypass grafting (CABG) surgery is one high-risk procedure
showing a consistent and comprehensive body of evidence,2-9 leading to a widespread
belief that if all patients were treated at high-volume hospitals, thousands of lives
would be saved each year. In the United States, in 2003, the Leapfrog hospital quality
initiative established an annual hospital volume of 450 CABG procedures to qualify
for premium bonus payments over and above the established fee schedule.10
Currently, the literature on the CABG volume-outcome relationship is limited to in-
patient or 30-day mortality,11 with little documentation on long-term outcomes. Using
nationwide population-based data from Taiwan’s National Health Insurance (NHI)
database, we examined the association between hospitals’ CABG surgery volumes
and long-term (5-year) patient outcomes. Under NHI, all citizens (.96% of the island’s
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CABG 5 coronary artery bypass grafting
ICD-9-CM 5 International Classification of Diseases–
ninth revision–Clinical Modification
MACE 5 major adverse cardiovascular event
NHI 5 National Health Insurance
PTCA 5 percutaneous transluminal coronary
angioplasty
population of about 23 million) have full choice of health care
provider under a single health benefit plan, a comprehensive
benefit package, and very low copayments. This structure en-
ables virtually full access to all citizens when they perceive
the need. Furthermore, all care, outpatient or inpatient, is
captured in the claims database, permitting every long-term
outcome to be tracked. This is unlike health systems, such
as that of the United States, where patient segmentation by
insurer, health plan, and provider panel disrupt the complete-
ness of information on postdischarge events and outcomes.
Furthermore, many other health care systems use gatekeeper
or referral systems that limit provider choice, confounding
volume-outcome studies. Taiwan’s NHI claims data provide
an opportunity to examine long-term outcomes without the
above-mentioned sources of selection bias or follow-up bias.
In this study we use major adverse cardiovascular events
(MACEs) as our outcome measure to examine the long-
term effects of hospital volume. MACE outcomes include
death, myocardial infarction, stroke, and repeat revasculari-
zation procedures (percutaneous transluminal coronary
angioplasty [PTCA] or repeated CABG). Rather than limit
to mortality alone, MACEs have been widely used to evalu-
ate the outcomes of cardiac procedures in the current litera-
ture.12-14 To date, MACEs have been used to evaluate
short-term outcomes of comparable/alternative care proce-
dures. Our study is innovative in presenting evidence on
long–term (rather than short-term) MACE outcomes (rather
than mortality alone) over a 5-year follow-up period relative
to hospital procedure volume.
Materials and Methods
Database
We linked NHI claims data with Taiwan’s Cause of Death file for the
years 1997 through 2004. These data cover all inpatient and outpa-
tient medical benefit claims for all citizens (.96% of the Taiwanese
population [23 million]). Each claim has International Classification
of Diseases–ninth revision–Clinical Modification (ICD-9-CM)
codes for 1 principal operative procedure, 1 principal diagnosis,
and up to 4 secondary diagnoses, along with details of the care
provided, patient demographics, and provider characteristics.
The Cause of Death file provides data on the date of death and
underlying cause of death (ICD-9-CM). Because of mandatory
death registration, these data are accurate and comprehensive.
Because these were deidentified secondary data released for public924 The Journal of Thoracic and Cardiovascular Surgery c Apaccess for research purposes, the study was exempt from full review
by the internal review board.
Study Sample
All in-patient claims for CABG surgery between January 1, 1997,
and December 31, 1999, were screened for the following: (1)
ICD-9 code 36.10-36.20 (bypass anastomosis for heart revasculari-
zation), (2) first-time CABG surgery for the patient, and (3) not
being an emergency department admission. NHI was implemented
in 1995, and paying for CABG operations out of pocket was beyond
the reach of most Taiwanese before 1995. NHI claims since 1995
were scrutinized to verify that the sample cases were first-time
CABG recipients. We excluded emergency CABG recipients
(admitted through the emergency department) because these
patients are documented to have disproportionately poor out-
comes.15,16 Based on the above criteria, we generated a study
sample of 5718 patients undergoing CABG surgery.
Hospital CABG Volume Groups
Based on unique hospital identifiers, we calculated each hospital’s
total CABG volume over the study period. Hospitals were then
sorted, in ascending order, according to their total CABG volume,
and cutoff points were determined by the volume that most closely
sorted the sample patients into 4 quartile groups of roughly equiva-
lent size. This is the standard documented method of classifying
patients by the provider’s procedure volume to obtain balanced
cell sizes for the volume groups.6 The 4 hospital volume groups
were 282 cases or less (low volume, n 5 1584 patients), 283 to
517 cases (medium volume, n 5 1317 patients), 518 to 725 cases
(high volume, n 5 1437 patients), and 726 cases or more (very
high volume, n 5 1380 patients).
Study end points. The study objective was to examine post-
CABG MACE-free survival at 30 days and 5 years (the latter
excluding patients with a MACE outcome within the first 30
days). This is because, relative to 5-year follow-up, 30-day
MACE incidence is more likely driven by initial disease severity
and by patient-specific clinical instability during the preoperative
and postoperative phases.
We identified 4 clinical end points (MACE qualifying outcome)
examined at 30 days and 5 years after each patient’s operative date:
death, myocardial infarction, stroke, and repeat revascularization
procedure (PTCA or repeat CABG). During each patient’s post-
CABG 30-day and 5-year periods, death (from Taiwan’s Cause of
Death file) or any subsequent inpatient claim or claims with a record-
ing of a MACE event was logged into the study database. In addi-
tion, a composite MACE outcome was defined: any patient with 1
or more of the 4 events/outcomes above was defined as having
a MACE outcome. The remaining patients were classified as
MACE-free survivors at 30 days and 5 years (after 30 days). The
composite definition of MACE-free survival in cardiovascular
medicine has been widely used in the current literature.12-14
Variables of interest. The patient was the unit of analysis. The
key independent variable was hospital volume. The dependent vari-
ables were dichotomous: having (or not having) a MACE within 30
days or 5 years (the denominator for the latter excluded patients with
any MACEs within 30 days). Both outcomes were evaluated as
hazard ratios by hospital volume.
We adjusted for patient and hospital characteristics. Patient
variables included age, sex, income, and clinical severity at firstril 2008
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CDadmission, as well as CABG procedure attributes. Income was
categorized as NT$0 (not working), NT$1 to NT$15,840 (income
less than minimum wage), NT$15841 to NT$25,000, and
NT$25,001 or greater. NT$15,840 is Taiwan’s minimum-wage
level stipulated for a full-time employee. Clinical severity was
captured by using 8 dichotomous (yes/no) variables: myocardial
infarction (ICD 410), any other coronary artery disease (ICD
411–414), diabetes (ICD 250), chronic obstructive pulmonary
disease (ICD 490–496), hypertension (ICD 401–405), renal
dysfunction (ICD 580–586), congestive heart failure (ICD 4280),
and stroke (ICD 430–438). We controlled for 2 CABG procedure
attributes (partly representing unmeasured clinical severity and
partly representing MACE propensity caused by operative complex-
ity): concomitant valve repair (ICD procedure code 35) and use of an
internal thoracic graft (ICD procedure code 36.15 and 36.16).
We adjusted for hospital and patient variables. Hospital vari-
ables included ownership (public, private not-for-profit [NFP],
and for-profit [FP]), hospital level (medical center, $500 beds; re-
gional hospital, 250–499 beds; and district hospital, #20 beds),
and geographic location (north, south, east, and central Taiwan).
Teaching status is excluded because all medical centers and
regional hospitals are teaching hospitals, which would cause colin-
earity. Medical centers and regional hospitals, as well as not-
for-profit status, are generally associated with state-of-the-art
clinical technologic infrastructure. Medical centers and regional
hospitals also have higher, round-the-clock, high-intensity moni-
toring of patients by residents, attending physicians, and teaching
faculty, as well as nursing students of various levels. Therefore be-
tween the 2 variables, hospital size and ownership, the regression
accounts for the facilities’ clinical technology infrastructure and
personnel support that might affect short-term and long-term
outcomes.
Statistical Analysis
The SAS statistical package (Version 8.2; SAS Institute, Inc, Cary,
NC) was used. Kaplan–Meier methods were used to estimate 30-day
and 5-year (after 30 days) MACE-free survival, and their associa-
tions with hospital volume were assessed by using the log-rank test.
Survival time was computed from the surgical date to the date of
MACE within the 30-day or (post-30-day) 5-year follow-up periods.
Cox proportional hazard regressions yielded hazard ratios that esti-
mate the contribution of hospital volume to MACE-free survival
adjusted for hospital and patient characteristics.
Results
Table 1 describes the distribution of the sample patients by
using severity measures at the time of CABG and CABG pro-
cedure attributes. Of 5718 first-time CABG hospitalizations,
the majority (76.8%) of patients was male, the mean age was
69.4 years (SD, 9.9), 99.2% had either myocardial infarction
or other coronary artery disease, and 29.1%, 38.4%, and
6.5% had diabetes, hypertension, and stroke, respectively.
Hospital and patient characteristics by hospital CABG
volume groups are presented in Table 2. Mean hospital
CABG volume for the study period was 214 operations.
The majority of low-volume hospitals were regional andThe Journal of Thonot-for-profit hospitals, and all very high-volume hospitals
were teaching hospitals (medical centers or regional hospi-
tals).
The in-hospital mortality rates were 3.5%, 3.9%, 2.9%, and
3.1% for low-, medium-, high- and very high-volume hospital
groups, respectively. The 30-day mortality rates were 4.2%,
4.3%, 4.2%, and 3.2% for low-, medium-, high- and very
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Hospital CABG volume group
Low (#282) Medium (283–517) High (518–725) Very high ($726)
Variable No. % Mean (SD) No. % Mean (SD) No. % Mean (SD) No. % Mean (SD)
Hospital characteristics*
No. of Hospitals 32 8 4 3
Mean of hospital CABG volume 95 (87) 445 (66) 698 (28) 922 (136)
Hospital level
Medical center 7 21.9 6 75.0 2 50.0 2 66.7
Regional hospital 21 65.6 2 25.0 1 25.0 1 33.3
District hospital 4 12.5 — — 1 25.0 —
Hospital ownership
Public 7 21.9 2 25.0 2 50.0 2 66.7
Private (not-for-profit) 16 50.0 5 62.5 2 50.0 1 33.3
Private (for-profit) 9 28.1 1 12.5 — — — —
Hospital Location
Northern 11 34.4 3 37.5 2 50.0 3 100
Central 11 34.4 1 12.5 1 25.0 — —
Southern 9 28.1 4 50.0 1 25.0 — —
Eastern 1 3.1 — — — — — —
Patient characteristicsy
Total no. of Patients 1584 27.7 1317 23.0 1437 25.1 1380 24.1
Mean age of patients (y) 68.8 (9.8) 69.3 (9.7) 68.4 (10.4) 71.0 (9.3)
Patient sex
Male 1155 72.9 1006 76.4 1086 75.6 1142 82.8
Female 429 27.1 311 23.6 351 24.4 238 17.3
Patient age
,65 y 453 28.6 349 26.5 445 31.0 287 20.8
65–74 y 643 40.6 547 41.5 582 40.5 506 36.7
.74 y 488 30.8 421 32.0 410 28.5 587 42.5
Coronary disease
MI as primary or
secondary diagnosis
39 2.5 12 0.9 14 1.0 27 2.0
Other coronary
artery disease
1530 96.5 1301 98.8 1411 98.2 1340 97.1
No coronary
artery disease
15 1.0 4 0.3 12 0.8 13 0.9
Diabetes
Yes 540 34.1 318 24.2 364 25.3 440 31.9
No 1044 65.9 999 75.8 1073 74.7 940 68.1
Hypertension
Yes 645 40.7 391 29.7 548 38.1 612 44.4
No 939 59.3 926 70.3 869 61.9 768 55.6
COPD
Yes 64 4.0 25 1.9 61 4.2 78 5.7
No 1520 96.0 1292 98.1 1376 95.8 1302 94.3
Renal disease
Yes 145 9.2 82 6.2 88 6.1 101 7.3
No 1439 90.8 1235 93.8 1349 93.9 1279 92.7
Congestive heart failure
Yes 167 10.5 38 2.9 152 10.6 54 3.9
No 1417 89.5 1279 97.1 1285 89.4 1326 96.1
Stroke
Yes 120 7.6 58 4.4 74 5.2 119 8.6
No 1464 92.4 1259 95.6 1363 94.8 1261 91.4926 The Journal of Thoracic and Cardiovascular Surgery c April 2008
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Hospital CABG volume group
Low (#282) Medium (283–517) High (518–725) Very high ($726)
Variable No. % Mean (SD) No. % Mean (SD) No. % Mean (SD) No. % Mean (SD)
Concomitant valve repair
Yes 107 6.8 78 5.9 100 7.0 116 8.4
No 1477 93.2 1239 94.1 1337 93.0 1264 91.6
Internal thoracic
artery graft
Yes 134 8.5 260 19.7 514 35.8 233 16.9
No 1450 91.5 1057 80.3 923 64.2 1147 83.1
Income-related insured
amount
0 557 35.2 432 32.8 552 38.4 350 25.4
NT$115,840 400 25.3 478 36.3 275 19.1 719 52.1
NT$15,84125,000 498 31.4 296 22.5 468 32.6 208 15.1
$NT$25,001 129 8.1 111 8.4 142 9.9 103 7.5
CABG, Coronary artery bypass grafting; SD, standard deviation; MI, myocardial infarction; COPD, chronic obstructive pulmonary disease. *Total number of
hospitals 5 47. yTotal patient sample 5 5718.high-volume hospital groups, respectively (data not shown).
Examined on the basis of individual MACE type, hospital
CABG volume is inversely associated with the 4 end
points and the composite end point, MACE, as shown in
Table 3. During the 5 years after CABG, low-volume hospi-
tals had the highest stroke and repeat CABG/PTCA rates,
which systematically decreased with increasing volume
category, although the differences did not attain statistical
significance. However, mortality accounted for a small pro-
portion (9%) of all MACE events (range, 6% to 12% across
volume groups). When the cause of mortality was investi-
gated, about one third of deaths were due to cardiovascular
causes, with the distribution of cardiovascular and noncardio-
vascular causes being similar across the 4 volume groups (data
not shown).
The crude 30-day and 5-year MACE-free survival rates, as
well as adjusted hazard ratios by hospital volume groups, are
provided in Table 4, showing increasing 30-day and 5-year
MACE-free survival rates with increasing hospital volume.The Journal of ThoCrude hazard ratio for a 30-day and 5-year MACE event
decreased with increasing hospital volume (30-day crude
hazard ratio for low-volume hospitals of 1.585 [reciprocal
of 0.631] relative to very high-volume hospitals). After
adjusting for patient demographics, initial case severity,
CABG procedure attributes, and hospital characteristics,
the negative association between hospital volume and
30-day and 5-year MACE hazard is sustained. Increasing
hospital volume predicts a systematic decrease in adjusted
MACE hazard at 5 years. The 30-day MACE hazard ratios
for patients in low-volume hospitals was 1.502 (P , .05)
relative to very high-volume hospitals. The 5-year MACE
hazard ratios for patients in low-volume hospitals were
1.131 (P , .01) and 1.233 (P , .001) relative to those of
patients in high-volume and very high-volume hospitals.
Discussion
This study makes a new contribution to the CABG volume-
outcome literature by investigating MACE hazard rather
A
CDTABLE 3. Five-year follow-up results (excluding those with a MACE within 30 days) by hospital CABG volumes, 1997–1999
Mortality Myocardial infarction Stroke Repeat CABG or PTCA All MACE
Yes No Yes No Yes No Yes No Yes No
Variables No. (%) No. (%) No. (%) No. (%) No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Hospital CABG volume
#282 50 (3.3) 1456 (96.7) 28 (1.9) 1478 (98.1) 165 (11.0) 1341 (89.0) 179 (11.9) 1327 (88.1) 422 (28.0) 1084 (72.0)
283–517 20 (1.6) 1235 (98.4) 13 (1.0) 1242 (99.0) 131 (10.4) 1124 (89.6) 143 (11.4) 1112 (88.6) 307 (24.5) 948 (75.5)
518–725 25 (1.8) 1347 (98.2) 20 (1.5) 1352 (98.5) 134 (9.8) 1238 (90.2) 138 (10.0) 1234 (90.0) 317 (23.1) 1055 (76.9)
$726 26 (1.9) 1308 (98.1) 14 (1.0) 1320 (99.0) 129 (9.7) 1205 (90.3) 106 (7.9) 1228 (92.1) 275 (20.6) 1059 (79.4)
Total patient sample5 5467.MACE, Major adverse cardiovascular event; CABG, coronary artery bypass grafting; PTCA, percutaneous transluminal coronary
angioplasty.racic and Cardiovascular Surgery c Volume 135, Number 4 927
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CDTABLE 4. Thirty-day and 5-year MACE-free survival (excluding those with a MACE within 30 days) and hazard ratios by









#282 95.1 1.000 1.000
283–517 95.3 1.019 (0.708–1.465) 0.952 (0.671–1.349)
518–725 95.5 0.780 (0.547–1.113) 0.922 (0.659–1.288)








#282 72.0 1.000 1.000
283–517 75.5 0.882 (0.797–0.976)z 0.912 (0.812–1.081)
518–725 76.9 0.855 (0.769–0.949)x 0.884 (0.809–0.965)x
$726 79.4 0.765 (0.689–0.850)k 0.811 (0.728–0.904)k
MACE, Major adverse cardiovascular event; CABG, coronary artery bypass grafting; CI, confidence interval. *Hazard ratios are adjusted for the patient's age,
sex, income-linked premium category, comorbidities, procedure attributes, and hospital characteristics, including hospital ownership, hospital level, and
geographic location. yTotal sample size 5 5718. zP , .05, xP , .01, and kP , .001. {Total sample size 5 5467.than mortality alone and by examining long-term MACE-
free survival rather than 30-day or inpatient mortality, which
has been the norm in these types of studies. It also distin-
guishes between 30-day and 5-year MACEs (after 30-days)
to sequester the high and variable vulnerability of the first
30 days from the relatively nonvolatile, post–30-day period.
Other key features that qualify its unique contribution are the
following: (1) the data’s ability to capture every subsequent
MACE event treated anywhere in Taiwan and linkages to
the Cause of Death data file and (2) coverage of all CABG
age groups throughout the country, unlike most documented
literature from the United States that focuses exclusively on
the Medicare population because of the inability to follow-
up younger age groups because of periodic churning in insur-
ance status and plan type. Although biases from these several
sources have confounded past efforts to investigate the true
relationship of provider volume with long-term outcomes,
our study is able to show that unequivocally, hospital
CABG volume affects MACE outcomes. Although our study
might not be readily replicable in many countries because of
a lack of such a data source, it makes a signal contribution by
providing empiric evidence for policymakers to benefit the
populace and to reduce health care costs arising from care-
intensive MACE outcomes.
Our findings indicate that the favorable association
between provider volume and in-hospital/30-day mortal-
ity5-10 extends beyond the immediate postoperative period
to 5 years after the operation. Furthermore, our study also
indicates that not only mortality but also intermediate events
and repeat revascularization in the following 5 years are less
frequent among patients treated by higher-volume providers
after adjusting for patient severity and other clinical charac-928 The Journal of Thoracic and Cardiovascular Surgery c Aprteristics, demographics, and income, as well as hospital char-
acteristics.
Our study also confirms that mortality represents the tip
of the iceberg of adverse outcomes (only 9% of all MACEs).
It demonstrates that limiting CABG outcome studies to
mortality alone would greatly underestimate the effect of
volume or, worse, fail to detect long-term outcome differ-
ences across volume groups. This is one likely reason why
the only documented study of long-term mortality versus
provider volume11 contradicts our finding. They reported no
difference in risk-adjusted 3-year survival at a low-volume
hospital compared with a high-volume hospital, when the
same high-volume surgeons performed the procedure. Other
reasons for their finding could be the following. First, they
compared 1 low-volume hospital in Ohio with 1 high-
volume hospital for a 5-surgeon team. Therefore lack of sta-
tistical power to compare hospital groups would preclude
statistically relevant conclusions. Second, in the United
States high-volume hospitals in metropolitan areas are very
likely teaching hospitals that are also safety net providers
to treat the uninsured, Medicaid, and African American
populations. Their patient profile confirms the significantly
higher proportions for these groups among the high-volume
hospital’s patients. Poorer risk-adjusted outcomes of
CABG operations (as well as most high-risk and chronic
conditions) among these groups is well documented. There-
fore their finding of no difference between the low-volume
and high-volume hospital could actually represent better
average performance by the high-volume hospital when
the generally poor risk-adjusted outcomes of the African
American, uninsured, and Medicaid population is taken into
account.il 2008
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alone, and yet we find that high volume predicts lower
adjusted mortality hazard. Because Taiwan has a universal
coverage, single-payer system with low copayments and an
ethnically homogeneous population, differences in treatment
by insurance status is not a source of confounding, rendering
our finding robust to extraneous confounding.
To explain our finding, 2 hypotheses are documented in
the literature. One is that ‘‘practice makes perfect,’’ causing
high-volume providers to have in place better care proce-
dures, recognition of potential complications before they su-
pervene, and better care organizations right up to discharge.17
The second documented hypothesis is that ‘‘self-referral’’
might cause more patients to attend hospitals with a reputa-
tion for better outcomes, causing such hospitals to become
high-volume hospitals.18 Although the former is possible,
the latter might also play a role in Taiwan19,20 because of
full provider choice, a considerable density of hospitals of
all types in the populated areas, and good transportation
systems.
Additionally, some researchers have suggested that the vol-
ume-outcome relationship in CABG surgery might result from
systematic differences in patient severity between low- and
high-volume providers.21,22 Many opponents of regionaliza-
tion policies have argued that administrative databases might
not permit adequate risk adjustment. We submit that our ad-
justment for a very comprehensive array of clinical risk factors
and the CABG attributes of internal thoracic artery graft use
and concomitant valve repair should have accounted for
most of the patient-specific vulnerabilities to MACEs. More-
over, we excluded all CABG cases admitted through the emer-
gency department, which also precludes a major source of
variance in clinical severity. Furthermore, it must be noted
that, in general, severely ill but not emergency patients are
most likely to choose medical centers or regional hospitals
(which are also large and noted for their state-of-the-art tech-
nologic infrastructure). Therefore it is unlikely that systemat-
ically higher unmeasured severity at low-volume hospitals is
driving our findings. Consistent with this reasoning, patients
treated at very high-volume hospitals had higher rates of con-
comitant valve repair and the use of internal thoracic artery
grafts than other volume groups. Other studies have also
shown that low-risk patients for cardiac interventions were
more likely to be treated by low-volume providers.23 Another
question could be that patients of lower socioeconomic status
could be disproportionately represented among the low-vol-
ume hospitals’ patient panels. Our adjustment for patient’s in-
come-linked premium deduction category takes care of this
potential source of confounding.
Finally, it could be argued that 5-year MACE differences
between low- and high-volume hospitals could be due to
lower all-cause mortality among the high-volume hospital
patients, in turn because of generally better medical and
surgical inpatient care for noncardiovascular morbiditiesThe Journal of Thosubsequent to their CABG surgery. Our finding that the
distribution of cardiovascular versus other cause of death is
similar across the volume groups rebuts this potential expla-
nation for our findings. Moreover, as explained earlier, mor-
tality contributes to less than 10% of total MACE incidence;
the sentinel cardiovascular MACEs independently show
a systematic (adjusted) decrease with increasing hospital
volume.
There are some study limitations. First, the claims data-
base lacks information on the clinical history of the patient,
such as cigarette smoking, alcohol consumption, left ventric-
ular ejection fraction, level of block and number of arteries
blocked, body mass index, creatinine levels, and clinical
severity scores. Yet with the large sample used, it is unlikely
that systematic differences in these factors are driving our
findings. A second limitation is that because of overall lower
CABG volumes in Taiwan compared with the United States
or other developed countries, we were unable to use the con-
ventional hospital volume thresholds documented in the liter-
ature for comparability of our findings across countries.
Notwithstanding the above limitations, the findings sug-
gest that high-volume hospitals have some processes, infra-
structure/personnel factors, or both that seem to produce
not only better short-term outcomes but also better long-
term outcomes. All high-volume hospitals are teaching hos-
pitals. Detailed comparative studies are necessary of the
care processes, medical and nursing monitoring, technical-
support infrastructure, and care provider interactions with
patients to understand what makes for better long-term
outcomes.
Theoretically, short-term outcomes could be attributed to
better surgical skills because of higher surgeon volumes. Yet
analysis of the above data by surgeon volume instead of hos-
pital volume does not show an association (data not shown).
Our finding that hospital volume, but not surgeon volume,
predicts adverse long-term outcomes is plausible for
a high-risk procedure such as CABG performed on high-
risk patients. The speedy and appropriate response of a hos-
pital’s preoperative and postoperative technical support and
skilled medical/nursing manpower can make or break a
patient’s MACE vulnerability.
Intuitively, one would expect that the above attributes
would affect short-term MACE survival, but one might ques-
tion why these institutional attributes would affect long-term
outcome. One possibility is that the high intensity of qualified
manpower in a teaching institution (eg, residents, medical
students, nursing students, and dieticians) might result in
a greater probability of appropriate advice and health educa-
tion support to patients to attend regular and full-scale check-
up visits, as well as to change their lifestyle and risk factors
after leaving the hospital.
Although the above explanations are clearly speculative,
they are presented as possible mediating variables underlying
our finding. The differences in long-term outcomes inracic and Cardiovascular Surgery c Volume 135, Number 4 929
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CDaddition to short-term outcomes amounts to 50% greater odds
of a MACE within 30 days (reciprocal of 0.666) among
patients in low-volume hospitals (adjusted for severity,
comorbidities, patient demographics, and other factors) and
an additional 23% greater (adjusted) MACE odds after 30
days but within 5 years (reciprocal of 0.811). This magnitude
of difference alone justifies detailed process studies by peer
task forces to leverage our findings into suitable professional
and policymaker interventions. The answer might not neces-
sarily be regionalization of high-risk procedures because
some low-volume hospitals can produce excellent long-
term outcomes and some high-volume hospitals can provide
poor outcomes. Only a detailed study of care processes and
services common to high-volume hospitals can provide guid-
ance to address this issue.
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